Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2021-12-08
2023-04-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Method: It is a randomized controlled experimental study. The sample of the study consisted of 84 nursing students. The students included in the study were divided into two equal groups: the experimental and control groups. Digital education material of the experimental group and theoretical education was applied to the control group. Before and after the training, a post-knowledge test was made and evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Digital Stories on Nursing Students' Medical Error and Safe Drug Administration
NCT07142460
The Effect of Digital Storytelling on Nursing Students' Compliance
NCT05022953
The Effect of Mobile Application Use on Drug Administration Knowledge and Skill Level of Pediatric Nursing Students
NCT06613451
The Effect of multımedıa-based educatıon ın dıstance learnıng on nursıng Students'
NCT05678855
The Effect of Screen-Based Simulation Training on Self-Efficacy and Self-Confidence in Learning
NCT06548659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Digital Education Group
All participants in this group were given the "Safe pediatric intravenous drug administration knowledge test" prepared by the researchers as a pre-test.
The participants of this group, who were determined by randomization, were given training prepared using the digital storytelling method. The training took 25 minutes.
After the training, the "Safe intravenous drug administration knowledge test" was applied as a post-test.
Digital Education Group
Providing training on safe pediatric intravenous drug administration with digital storytelling method
Control Group
No intervention was made. All participants in this group were given the "Safe pediatric intravenous drug administration knowledge test" prepared by the researchers as a pre-test.
Afterward, theoretical information on the subject was given. After theoretical information, the "Safe intravenous drug administration knowledge test" was applied as a post-test.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digital Education Group
Providing training on safe pediatric intravenous drug administration with digital storytelling method
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Taking the child health and diseases nursing course and being successful
* Volunteering to participate in the research
Exclusion Criteria
* Being a 1st and 2nd year nursing student
* Failure of the child health and diseases nursing course
19 Years
23 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Izmir Bakircay University
OTHER
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Şeyda BİNAY YAZ
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Semih Akkoyun
Role: PRINCIPAL_INVESTIGATOR
Izmir Bakircay University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Semih
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Bakircay
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.